Explore ARDC

RAiD https://raid.org/10.82287/e2500756
Pipeline Accelerator - Voucher Scheme - 23-24 Round 1

Dates

Start Date
01-Sep-2023
End Date
30-Dec-2023

Titles

Title
Pipeline Accelerator - Voucher Scheme - 23-24 Round 1
Title Type
Primary
Title Type:
Primary
 Preferred full description or abstract.
Start Date
01-Sep-2023
End Date
30-Dec-2023
Language
English

Descriptions

No Entries

Contributors

Leader
Yes
Contact
Yes
Positions
Position
Principal or Chief Investigator
Position:
Principal or Chief Investigator
 Principal investigator refers to the person(s) in charge of a research project
Start Date
01-Sep-2023
End Date
---
Roles
No Entries

Organisations

Name
Phenomics Australia

Roles
Role
Lead Research Organisation
Role:
Lead Research Organisation
 The research organistion administratively responsible for the project; administering organisation
Start Date
2023-07-01
End Date
---

RelatedObjects

Citation

Phenomics Australia. (2023). High throughput screening to identify new therapeutic strategies for mucinous ovarian cancer patients. Phenomics Australia.
Type
Funding
Categories
Output
Citation

Phenomics Australia. (2023). Development of iPSC models for ASO screening for TRAPPC4 neurodevelopmental disorder. Phenomics Australia.
Type
Funding
Categories
Output
Citation

Phenomics Australia. (2023). Generation of Oral Carcinoma Patient-Derived Organoids for Personalised Cancer Research. Phenomics Australia.
Type
Funding
Categories
Output
Citation

Phenomics Australia. (2023). Personalised treatment strategies for patients with early-onset metastatic colorectal cancer. Phenomics Australia.
Type
Funding
Categories
Output
Citation

Phenomics Australia. (2023). Methodology development for high-throughput compound screeing of primary human immune cell cytotoxicity in 3D. Phenomics Australia.
Type
Funding
Categories
Output
Citation

Phenomics Australia. (2023). Development of human GPCR knock-in mice for assessment of therapeutic antibodies. Phenomics Australia.
Type
Funding
Categories
Output
Citation

Phenomics Australia. (2023). Establishing a targeted treatment strategy using epigenetic reprogramming against adverse EMT-induced tumour plasticity in head and neck (oral) squamous cell carcinoma. Phenomics Australia.
Type
Funding
Categories
Output
Citation

Phenomics Australia. (2023). Developing a human induced pluripotent stem cell reporter line for heart valve disease modelling. Phenomics Australia.
Type
Funding
Categories
Output
Citation

Phenomics Australia. (2023). Generation of mouse models of inherited heart failure to test the efficacy of novel stem cell based therapies. Phenomics Australia.
Type
Funding
Categories
Output

Alternate Identifier

No Entries

Alternate URLs

No Entries

Related RAiDs

No Entries

Access

Type
Open Access
Type:
Open Access
 Open access refers to a resource that is immediately and permanently online, and free for all on the Web, without financial and technical barriers.The resource is either stored in the repository or referenced to an external journal or trustworthy archive.
Language
Text
Embargo Expiry

Subjects

No Entries

Raw Data

{
  "access": {
    "type": {
      "id": "https://vocabularies.coar-repositories.org/access_rights/c_abf2/",
      "schemaUri": "https://vocabularies.coar-repositories.org/access_rights/"
    }
  },
  "alternateIdentifier": [],
  "alternateUrl": [],
  "contributor": [
    {
      "contact": true,
      "id": "https://orcid.org/0000-0002-5324-8398",
      "leader": true,
      "position": [
        {
          "id": "https://vocabulary.raid.org/contributor.position.schema/307",
          "schemaUri": "https://vocabulary.raid.org/contributor.position.schema/305",
          "startDate": "2023-09-01"
        }
      ],
      "role": [],
      "schemaUri": "https://orcid.org/",
      "status": "AUTHENTICATED",
      "orcidInfo": {
        "orcidId": "0000-0002-5324-8398",
        "displayName": "Michael Dobbie",
        "nameType": "constructed",
        "visibility": "public",
        "authenticated": true,
        "claimed": true,
        "verified": false,
        "profileUrl": "https://orcid.org/0000-0002-5324-8398",
        "style": "underline"
      }
    }
  ],
  "date": {
    "endDate": "2023-12-30",
    "startDate": "2023-09-01"
  },
  "description": [],
  "identifier": {
    "id": "https://raid.org/10.82287/e2500756",
    "license": "Creative Commons CC-0",
    "owner": {
      "id": "https://ror.org/0201hm243",
      "schemaUri": "https://ror.org/",
      "servicePoint": 20000016,
      "servicePointName": "PhenomicsAus"
    },
    "raidAgencyUrl": "https://static.prod.raid.org.au/raids/10.82287/e2500756",
    "registrationAgency": {
      "id": "https://ror.org/038sjwq14",
      "schemaUri": "https://ror.org/"
    },
    "schemaUri": "https://raid.org/",
    "version": 5
  },
  "metadata": {
    "created": 1780357040,
    "updated": 1780464536
  },
  "organisation": [
    {
      "id": "https://ror.org/0201hm243",
      "role": [
        {
          "id": "https://vocabulary.raid.org/organisation.role.schema/182",
          "schemaUri": "https://vocabulary.raid.org/organisation.role.schema/359",
          "startDate": "2023-07-01"
        }
      ],
      "schemaUri": "https://ror.org/",
      "rorDetails": {
        "rorId": "0201hm243",
        "name": "Phenomics Australia",
        "type": "Organization",
        "rorUrl": "https://ror.org/0201hm243"
      }
    }
  ],
  "relatedObject": [
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/0rjn-2b18",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2023). <i>High throughput screening to identify new therapeutic strategies for mucinous ovarian cancer patients</i>. Phenomics Australia."
      }
    },
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/52qh-h634",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2023). <i>Development of iPSC models for ASO screening for TRAPPC4 neurodevelopmental disorder</i>. Phenomics Australia."
      }
    },
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/megh-9025",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2023). <i>Generation of Oral Carcinoma Patient-Derived Organoids for Personalised Cancer Research</i>. Phenomics Australia."
      }
    },
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/2b6r-gx60",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2023). <i>Personalised treatment strategies for patients with early-onset metastatic colorectal cancer</i>. Phenomics Australia."
      }
    },
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/n1xy-vk83",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2023). <i>Methodology development for high-throughput compound screeing of primary human immune cell cytotoxicity in 3D</i>. Phenomics Australia."
      }
    },
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/sfzj-8a72",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2023). <i>Development of human GPCR knock-in mice for assessment of therapeutic antibodies</i>. Phenomics Australia."
      }
    },
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/9603-1820",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2023). <i>Establishing a targeted treatment strategy using epigenetic reprogramming against adverse EMT-induced tumour plasticity in head and neck (oral) squamous cell carcinoma</i>. Phenomics Australia."
      }
    },
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/wbza-7b96",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2023). <i>Developing a human induced pluripotent stem cell reporter line for heart valve disease modelling</i>. Phenomics Australia."
      }
    },
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/tbn7-6d23",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2023). <i>Generation of mouse models of inherited heart failure to test the efficacy of novel stem cell based therapies</i>. Phenomics Australia."
      }
    }
  ],
  "relatedRaid": [],
  "spatialCoverage": [],
  "subject": [],
  "title": [
    {
      "endDate": "2023-12-30",
      "language": {
        "id": "eng",
        "schemaUri": "https://www.iso.org/standard/74575.html"
      },
      "startDate": "2023-09-01",
      "text": "Pipeline Accelerator - Voucher Scheme - 23-24 Round 1",
      "type": {
        "id": "https://vocabulary.raid.org/title.type.schema/5",
        "schemaUri": "https://vocabulary.raid.org/title.type.schema/376"
      }
    }
  ]
}

Page generated: